Teva Pharmaceutical Industries (TEVA): Officer filed to sell ~$1.93M

~$1.93M

planned to sell · 46K shares, around Nov 5, 2026

Planned for

Nov 5, 2026

Notice filed

Nov 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 16, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
2. Oct 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 27, 2026, at a meeting of the Board of Directors (the “Board”) of Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”), the Board elected Dr. David J. Brailer to serve as a member of the Board, effective November 3, 2026, until Teva’s 2027 annual meeting of shareholders.”
3. Nov 2, 20265% stakeHarel Insurance Investments & Financial Services Ltd. reported a passive stake (13G) of 6.0%
4. Nov 3, 2026Company filing · Form 8-K · ResultsReported its results
5. Nov 4, 2026Insider · 1 personInsiders: 2 sales (~$1.1M)
6. Nov 5, 2026InsiderOfficer sold ~$1.93M of TEVA shares in the open market

What came next

1. Nov 9, 2026Insider · 2 peopleInsiders: 4 sales (~$1.8M)
2. Nov 10, 20265% stakeMENORA MIVTACHIM HOLDINGS LTD. reported a passive stake (13G) of 5.0%
3. Nov 10, 2026Insider · Their largest sale since 2024CEO sold ~$10.6M of TEVA shares in the open market
4. Nov 11, 2026InsiderOfficer sold ~$856K of TEVA shares in the open market
5. Nov 12, 2026InsiderOfficer sold ~$1.97M of TEVA shares in the open market

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Teva Pharmaceutical Industries

For Teva Pharmaceutical Industries, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TEVA page.

How this filing works

• SEC Form 144
• Rule 10b5-1 trading plans

Other disclosures at Teva Pharmaceutical Industries

• SEC Form 144Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026

Everything OQRO holds on this company is on its TEVA page.